0|10000|Public
5000|$|... <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] )( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] )( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] )( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) ...|$|R
40|$|Contents 1 Background 4 1. <b>1</b> Introduction................................ <b>4</b> <b>1.</b> <b>2</b> Types of {{handwriting}} recognition systems................ 5 <b>1.</b> <b>2.</b> <b>1</b> Ooe-line recognition........................ 5 <b>1.</b> <b>2.</b> 2 On-line recognition........................ 5 <b>1.</b> <b>2.</b> 3 Character sets........................... 6 <b>1.</b> <b>2.</b> <b>4</b> Writing style variations...................... 7 <b>1.</b> <b>2.</b> <b>4.</b> <b>1</b> Variations of characters................ 7 <b>1.</b> <b>2.</b> <b>4.</b> <b>2</b> Alignment of characters................ 8 <b>1.</b> <b>2.</b> <b>4.</b> 3 Personal background factors.............. 8 <b>1.</b> <b>2.</b> <b>4.</b> 4 Situational factors................... 9 <b>1.</b> <b>2.</b> <b>4.</b> 5 Material factors..................... 9 <b>1.</b> <b>2.</b> <b>4.</b> 6 Constraints on writing................. 9 <b>1.</b> <b>2.</b> 5 Context.............................. 10 1. 3 Beneø...|$|R
40|$|The Dimroth {{rearrangement}} in ring-fused <b>1,</b> <b>2,</b> <b>4</b> -triazoles {{has been}} reviewed {{in detail in}} Part I and the synthesis of all known triazolo-triazines is described in Part II. Experimental investigations concerned the establishinent of the skeletal arrangement {{of a variety of}} triazolotriazines formed by several synthetic routes. Interaction of 3 -amino- 5 -hydrazino- 12, 4 -triazole and benzilafforded 2 -amino- 6, 7 -diphenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -c-]- <b>1,</b> <b>2,</b> <b>4</b> -triazine,whereas cyclization of 5, 6 -diphenyl- 3 -hydrazino- <b>1,</b> <b>2,</b> <b>4</b> -triazine withcyanogen bromide resulted in the isomeric 3 -amino- 6, 7 -diphenyl,- <b>1,</b> <b>2,</b> <b>4</b> -triazolo [4, 3 -b]- <b>1,</b> <b>2,</b> <b>4</b> -triazine: both amines were deaminated with amyl nitrite in boiling tetrahydrofuran without rearrangement of the heterocyclic skeleton. 6, 7 -Diphenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -cJ- <b>1,</b> <b>2.</b> <b>4</b> -triazine, synthesized from 3 -hydrazino- <b>1,</b> <b>2,</b> <b>4</b> -triazole and benzil, formed a covalent hydrate which could be detected spectroscopically in solution, and a covalemt methanolate and ethanolate which could be isolated. A new route to 3 -amino- 5 -hydrazino-pyrazole is described and cyclization to 7 -amino- 3, 4 -diphenyl-pyrazolo[5, 1 -. c]- <b>1,</b> <b>2,</b> <b>4</b> -triazine was achieved with benzil. The diazonium nitrate of 3 -amino- <b>1,</b> <b>2,</b> <b>4</b> -triazole coupled with ethyl cyanoacetate to yield a mixture of two geometrical isomers of ethyl <b>2</b> -(2 H- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 3 -ylhydrazono) cyanoacetate. Recrystallization of the crude coupling mixture from aqueous ethanol gave a single hydra-zone which cyclized predominantly to ethyl 7 -amino- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> -triazine- 6 -carboxylate in acid conditions and 6 -cyano- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> ~triazin- 7 (4 H) -one under basic conditions. The nature of the cyclizing medium also controlled the cyclization of. the (pyrazol-ylhydrazono) cyanoacetate hut the corresponding (tetrazol- ylhydrazono) cyanoacetate gave only ethyl 7 -aminotetrazolo[5, <b>1</b> -cJ- <b>1,</b> <b>2,</b> <b>4</b> - -triazine- 6 -carboxylate. <b>2</b> -(2 H- <b>1,</b> <b>2,</b> <b>4</b> -Triazol- 3 -:ylhydrazono) malonitrile cyclized unambiguously to 7 -amino- 6 -cyano- <b>1,</b> <b>2,</b> <b>4</b> -triazolo-[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> - triazine. Drastic hydrolysis of ethyl <b>2</b> -(2 H- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 3 -yllhydrazono) -cyanoacetate, ethyl 7 -amino- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> -triazine- 6 -carboxylate, 6 -cyano- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> -triazin- 7 { 4 H) -one and 7 -amino- 6 - cyano- <b>1,</b> <b>2,</b> <b>4</b> -triazolo[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> -triazine gave a hydrate of <b>1,</b> <b>2,</b> <b>4</b> -triazo <b>1</b> o[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> -triazin- 7 (4 H) -one. Mass spectral fragmentations of 7 -aminoazolo-[5, <b>1</b> -c]- <b>1,</b> <b>2,</b> <b>4</b> -triazinesconfirm that the azole ring is more stable than the <b>1,</b> <b>2,</b> <b>4</b> -triazine ring on electron impact...|$|R
5000|$|... <b>1</b> <b>4</b> <b>2</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>4</b> <b>2</b> 5 8 [...] )( [...] <b>1</b> <b>4</b> <b>2</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ), Swap since <b>4</b> > <b>2</b> ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] )( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] ) [...] ( [...] <b>1</b> <b>2</b> <b>4</b> 5 8 [...] )Now, {{the array}} is already sorted, but the {{algorithm}} {{does not know}} if it is completed. The algorithm needs one whole pass without any swap to know it is sorted.|$|R
2500|$|... (2): Interchanging two (6 elements: { (<b>1,</b> <b>2,</b> <b>4,</b> 3), (<b>1,</b> <b>4,</b> 3, <b>2),</b> (<b>1,</b> 3, <b>2,</b> <b>4),</b> (<b>4,</b> <b>2,</b> 3, <b>1),</b> (3, <b>2,</b> <b>1,</b> <b>4),</b> (<b>2,</b> <b>1,</b> 3, <b>4)</b> }) ...|$|R
5000|$|... (3): A cyclic {{permutation}} of three (8 elements: { (<b>1,</b> 3, <b>4,</b> <b>2),</b> (<b>1,</b> <b>4,</b> <b>2,</b> 3), (3, <b>2,</b> <b>4,</b> <b>1),</b> (<b>4,</b> <b>2,</b> <b>1,</b> 3), (<b>4,</b> <b>1,</b> 3, <b>2),</b> (<b>2,</b> <b>4,</b> 3, <b>1),</b> (3, <b>1,</b> <b>2,</b> <b>4),</b> (<b>2,</b> 3, <b>1,</b> <b>4)</b> } [...] ) ...|$|R
40|$|In {{the title}} compound, C 8 H 8 N 4 &# 183;C 8 H 8 N 4, two tautomers, viz. 3 -phenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 5 -amine and 5 -phenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 3 -amine, are {{crystallized}} together in equal amounts. The 3 -phenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 5 -amine molecule is essentially planar; the phenyl ring makes a dihedral angle of 2. 3 &# 8197;(2) &# 176; with the mean {{plane of the}} <b>1,</b> <b>2,</b> <b>4</b> -triazole ring. In the 5 -phenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 3 -amine tautomer, the mean planes of the phenyl and <b>1,</b> <b>2,</b> <b>4</b> -triazole rings form a dihedral angle of 30. 8 &# 8197;(2) &# 176;. The &# 960;-electron delocalization of the amino group with the <b>1,</b> <b>2,</b> <b>4</b> -triazole nucleus in the 3 -phenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 5 -amine molecule is more extensive than that in the 5 -phenyl- <b>1,</b> <b>2,</b> <b>4</b> -triazol- 3 -amine tautomer. The molecules are linked into a two-dimensional network parallel to (100) by N&# 8212;H [...] . N hydrogen bonds...|$|R
2500|$|... (3): A cyclic {{permutation}} of three (8 elements: [...] { (<b>1,</b> 3, <b>4,</b> <b>2),</b> (<b>1,</b> <b>4,</b> <b>2,</b> 3), (3, <b>2,</b> <b>4,</b> <b>1),</b> (<b>4,</b> <b>2,</b> <b>1,</b> 3), (<b>4,</b> <b>1,</b> 3, <b>2),</b> (<b>2,</b> <b>4,</b> 3, <b>1),</b> (3, <b>1,</b> <b>2,</b> <b>4),</b> (<b>2,</b> 3, <b>1,</b> <b>4)</b> } [...] ) ...|$|R
40|$|The {{reaction}} of various <b>1,</b> <b>2,</b> <b>4</b> -oxadiazoles with {{an excess of}} hydrazine in DMF has been investigated. 3 -Amino- <b>1,</b> <b>2,</b> <b>4</b> -triazoles are produced through a reductive ANRORC pathway consisting of the addition of hydrazine to the <b>1,</b> <b>2,</b> <b>4</b> -oxadiazole followed by ring-opening, ring-closure, and final reduction of the 3 -hydroxylamino- <b>1,</b> <b>2,</b> <b>4</b> -triazole intermediate. The general applicability of <b>1,</b> <b>2,</b> <b>4</b> -oxadiazoles ANRORC reactivity is demonstrated also {{in the absence of}} C(5) -linked electron-withdrawing groups...|$|R
40|$|New {{fluorine}} substituted heterobicyclic {{nitrogen system}} as imidozolopyrimidines (<b>2,</b> 3), pyrimido- <b>1,</b> <b>2,</b> <b>4</b> -triazinones (<b>4</b> - 7), <b>1,</b> <b>2,</b> <b>4</b> -triazinyl- <b>1,</b> <b>2,</b> <b>4</b> -triazine (12 - 16), <b>1,</b> <b>2,</b> <b>4</b> -triazinyl- <b>1,</b> <b>2,</b> <b>4</b> -triazinones (14 - 17) and substituted thiobarbituric acids (19 - 20), have been synthesized using {{the reaction of}} 3 -amino- 5, 6 -di (<b>4</b> ′-fluorophenyl) - <b>1,</b> <b>2,</b> <b>4</b> -triazine (<b>1)</b> with α,β–bifunctional compounds. Structures of the title compounds were characterized by UV, IR, 1 H/ 13 C-NMR and mass spectrometric method. The studied compounds were tested for CDK 2 inhibiting activity in DNA damage, {{as well as in}} vitro anti-tumor activity...|$|R
40|$|We have {{reported}} 1 {{the synthesis of}} 6, 5 '-bis- <b>1,</b> <b>2,</b> <b>4</b> -triazinyls and 6, 6 '-bis- <b>1,</b> <b>2,</b> <b>4</b> -triazinyls by the cyclization of <b>1</b> -hetero-aryl- <b>2</b> -(3 -N,N-dimethylamino- <b>1,</b> <b>2,</b> <b>4</b> -triazin- 6 -yl) -ethandione derivatives with methylthiosemicarbazide hydrogen iodide (1), where we assumed that the major product was the 6, 5 '-bis- <b>1,</b> <b>2,</b> <b>4</b> -triazinyls. As extention of our previous research, we attempt to synthesize the 3 -N,N-dimethylamino- <b>1,</b> <b>2,</b> <b>4</b> -tri-azin- 6 -yl-glyoxal (2). We believed that the carbon of alde-hyde group is definitely more electrophilic than that of keto, and the reaction with methylthiosemi- carbazide hydrogen iodide (1) will produce the 6, 5 '-bis- <b>1,</b> <b>2,</b> <b>4</b> -triazinyls as major product. By comparing 1 H NMR of compounds 7 and 8, we could easily distinguish between 6, 5 '- (7) and 6, 6 '-bis- <b>1,</b> <b>2,</b> <b>4</b> -triazinyls (8). Now {{we would like to}} report the synthe-sis of the first <b>1,</b> <b>2,</b> <b>4</b> -triazinylglyoxal derivative, which i...|$|R
5000|$|Clevie - drums (tracks <b>1,</b> <b>2,</b> <b>4,</b> 12), {{percussion}} (tracks <b>1,</b> <b>2,</b> <b>4,</b> 12) ...|$|R
5000|$|Paul Franklin - steel guitar (<b>1,</b> <b>2,</b> <b>4,</b> 7), dobro (<b>1,</b> <b>2,</b> <b>4,</b> 7) ...|$|R
2500|$|... (4): A cyclic {{permutation}} {{of all four}} (6 elements: { (<b>2,</b> 3, <b>4,</b> <b>1),</b> (<b>2,</b> <b>4,</b> <b>1,</b> 3), (3, <b>1,</b> <b>4,</b> <b>2),</b> (3, <b>4,</b> <b>2,</b> <b>1),</b> (<b>4,</b> <b>1,</b> <b>2,</b> 3), (<b>4,</b> 3, <b>1,</b> <b>2)</b> } [...] ) ...|$|R
5000|$|... <b>1,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> 3, 10, 3, <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>4,</b> 1, 29, 14, <b>1,</b> <b>1,</b> 14, <b>2,</b> <b>1,</b> <b>2,</b> <b>4,</b> <b>1,</b> <b>2,</b> <b>4,</b> 5, 12, <b>2,</b> <b>1,</b> <b>2,</b> <b>2,</b> 9, 16, <b>1,</b> <b>2,</b> 80, <b>1,</b> <b>2,</b> <b>4,</b> <b>2,</b> 3, 16, <b>2,</b> <b>2,</b> <b>2,</b> <b>1,</b> 15, 960, 15, 1, 4, 3, 1, 14, 1, 6, 20, 1, 3, 946, 6, 1, 18, 10, 1, 4, 1, 5, 42, 4, 1, 828, <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> 12, <b>2,</b> 6, <b>4,</b> 30, 3, 3022, <b>2,</b> <b>1,</b> <b>1,</b> 8, <b>2,</b> <b>4,</b> <b>4,</b> <b>2,</b> 11, 8, <b>2,</b> <b>1,</b> ...|$|R
5000|$|Ken Marshall - mixing (<b>1,</b> <b>2,</b> <b>4,</b> 6, 7), {{additional}} production (<b>1,</b> <b>2,</b> <b>4,</b> 6, 7) ...|$|R
40|$|AbstractIn {{this work}} we study the reverse order laws for { <b>1,</b> <b>2,</b> 3 }- and { <b>1,</b> <b>2,</b> <b>4</b> }-inverses {{of a product}} of two {{matrices}} by using the expressions for maximal and minimal ranks of the generalized Schur complement. The necessary and sufficient conditions for B{ <b>1,</b> <b>2,</b> 3 }A{ <b>1,</b> <b>2,</b> 3 }⊆(AB) { <b>1,</b> <b>2,</b> 3 } and B{ <b>1,</b> <b>2,</b> <b>4</b> }A{ <b>1,</b> <b>2,</b> <b>4</b> }⊆(AB) { <b>1,</b> <b>2,</b> <b>4</b> } are presented...|$|R
5000|$|Walter Afanasieff - {{keyboards}} (<b>1,</b> <b>2,</b> <b>4,</b> 5), synth bass (<b>1,</b> <b>2,</b> <b>4,</b> 5), drum programming (<b>2,</b> <b>4,</b> 5), co-producer (4, 5) ...|$|R
40|$|New {{fluorinated}} bent-core mesogens {{containing the}} <b>1,</b> <b>2,</b> <b>4</b> -oxadiazole or <b>1,</b> <b>2,</b> <b>4</b> -triazole nucleus have been synthesized {{taking advantage of}} the ANRORC (Addition of Nucleophile, Ring-Opening, Ring-Closure) reactivity of 5 -perfluoroalkyl- <b>1,</b> <b>2,</b> <b>4</b> -oxadiazoles. Physical state changes of the obtained compounds were characterized through DSC, POM, and SAXS. Besides the formation of a smectic mesophase, a novel behavior as organic molecular glass was evidenced for some <b>1,</b> <b>2,</b> <b>4</b> -oxadiazole derivatives...|$|R
5000|$|Silver coins {{were issued}} {{in the name}} of the [...] "Río de la Plata Province" [...] in {{denominations}} of ½, <b>1,</b> <b>2,</b> <b>4</b> and 8 reales and ½, <b>1,</b> <b>2,</b> <b>4</b> and 8 soles, whilst gold coins (87.5%) were issued in denomination of <b>1,</b> <b>2,</b> <b>4</b> and 8 escudos.|$|R
5000|$|Narada Michael Walden - {{producer}} (<b>1,</b> <b>2,</b> <b>4,</b> 5), arrangements (<b>1,</b> <b>2,</b> <b>4,</b> 5), Simmons drums (<b>1),</b> Prophet synthesizer (<b>2),</b> Roland synthesizer (2) ...|$|R
5000|$|Steve Harvey - {{producer}} (<b>1,</b> <b>2,</b> <b>4),</b> electronic programming (<b>1,</b> <b>2,</b> <b>4),</b> additional keyboards (<b>1,</b> 4), vocal arrangements (<b>1,</b> <b>4),</b> arrangements (<b>2),</b> backing vocals (<b>4)</b> ...|$|R
40|$|Syntheses of {{a series}} of 3, 5 -diaryl- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole {{derivatives}} are described. In this present work, 4 -amino- 3 -phenyl- 5 -p-tolyl- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole(1) was converted to N,N’-bis[3 -phenyl- 5 -p-tolyl- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazolyl]- <b>1,</b> 4 -xylenediimine(2) and 3 -Phenyl- 5 -p-tolyl- 4 -[4 -methyl benzylidenamino]- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole (3) in good yields by treatment with aldehydes OHC-C 6 H 4 -CHO and Ar-CHO respectively. The compounds N,N’-bis [3 -phenyl- 5 -p-tolyl- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazolyl]- <b>1,</b> <b>4</b> -xylenediimine (<b>2)</b> and 3 -phenyl- 5 -p-tolyl- 4 -[4 -methyl benzylidenamino]- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole (3) were reduced with NaBH 4 to afford the corresponding compounds N,N’-bis [3 -phenyl- 5 [...] tolyl- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazolyl]- <b>1,</b> 4 -xylenediamine (4) and 3 -phenyl- 5 -p-tolyl- 4 -[4 -methyl benzylamino]- <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole (5) respectively. The newly synthesized compounds were characterized by spectral and elemental analyses. All the synthesized compounds were tested for their antifungal activity against P. oryzae, B. cinerea, A. niger, C. albicans and T. rubrum...|$|R
40|$|The {{action of}} most common {{oxidising}} agents on <b>1,</b> <b>2,</b> <b>4</b> - triazoline - 3 -thione leads to ready cleavage of the C-S bond to yield <b>1,</b> <b>2,</b> <b>4</b> -triazole. Prior to this work no <b>1,</b> <b>2,</b> <b>4</b> -triazole - 3 -sulphonic acids had been reported. Several oxidative {{methods have been}} developed which yield <b>1,</b> <b>2,</b> <b>4</b> -triazole - 3 -sulphonic acid; of these chlorine oxidation is the most convenient. A literature survey of the oxidation of heterocyclic thiols and thiones has been made. Syntheses of substituted <b>1,</b> <b>2,</b> <b>4</b> - triazoline - 3 -thiones have been reviewed. Thirty monosubstituted <b>1,</b> <b>2,</b> <b>4</b> -triazoline - 3 -thiones {{as well as several}} disubstituted <b>1</b> <b>1</b> <b>2,</b> <b>4</b> -triazoline- 3 -thiones, <b>1,</b> <b>2</b> <b>1</b> <b>4</b> - triazolidine - 3, 5 -dithiones, di -(1, <b>2,</b> <b>4</b> -triazoline - 3 -thiones), and fused ring <b>1,</b> <b>2,</b> <b>4</b> -triazoline - 3 -thiones have been prepared. Chlorine oxidation of all these compounds has been investigated. In most cases the corresponding sulphonyl chlorides were formed initially, and these were then hydrolysed to the sulphonic acid or converted to the sulphonamide. Approximately thirty acids and fifteen amides were prepared in this way. With certain <b>2</b> -substituted <b>1,</b> <b>2,</b> <b>4</b> -triazoline - 3 -thiones no sulphonyl chlorides nor sulphonic acids could be isolated, while with certain substituents in the 4 -position the intermediate sulphonyl chlorides were formed but could not be converted into the corresponding sulphonic acids. Bromine oxidation of several monosubstituted <b>1,</b> <b>2,</b> <b>4</b> - triazoline - 3 -thiones also yielded the corresponding sulphonic acids though yields were very poor for the parent thione...|$|R
5000|$|Background vocals: Mercy Stevens (<b>1,</b> <b>2,</b> <b>4),</b> Philip King (<b>1,</b> <b>2),</b> Sam Hancock (<b>1,</b> <b>2,</b> <b>4),</b> Skye Parrish (<b>1,</b> <b>2),</b> Christopher Stevens (<b>1,</b> <b>2,</b> <b>4),</b> Michael W. Smith (1-4), Seth Mosley (3, 5, 9, 11), Bryan Fowler (4), Stephen Duncan (5), Lauren Daigle (5), Gabe Kossol (6), Jeremy Edwardson (6, 8), Andrew Ehernzeller (10), Laura Cooksey (11), Bellarive (12) ...|$|R
5000|$|... <b>1,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> 3, <b>2,</b> <b>1,</b> <b>1,</b> <b>4,</b> <b>2,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> 5, <b>2,</b> <b>1,</b> 3, <b>2,</b> <b>1,</b> <b>1,</b> 8, <b>2,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>4,</b> <b>2,</b> <b>1,</b> <b>2,</b> <b>1,</b> 7, <b>2,</b> <b>1,</b> 3, <b>4,</b> <b>2,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> 7, <b>4,</b> 5, 3, <b>4,</b> <b>2,</b> <b>1,</b> <b>2,</b> <b>1,</b> 3, <b>2,</b> <b>1,</b> 1, 10, 3, 3, <b>2,</b> <b>1,</b> 1, ...|$|R
40|$|The {{transformation}} of <b>1,</b> <b>2,</b> <b>4</b> -trichlorobenzene (<b>1,</b> <b>2,</b> <b>4</b> -TCB) at initial concentrations in nano- and micromolar ranges was studied in batch experiments with Burkholderia sp. strain PS 14. <b>1,</b> <b>2,</b> <b>4</b> -TCB was metabolized from nano- and micromolar concentrations to below its detection limit of 0. 5 nM. At low initial <b>1,</b> <b>2,</b> <b>4</b> -TCB concentrations, a first-order relationship between specific transformation rate and substrate concentration was observed {{with a specific}} affinity (a 0 A) of 0. 32 liter · mg (dry weight) − 1 · h− 1 followed by a second one at higher concentrations with an aoA of 0. 77 liter · mg (dry weight) − 1 · h− 1. This transition from the first-order kinetics at low initial <b>1,</b> <b>2,</b> <b>4</b> -TCB concentrations to the second first-order kinetics at higher <b>1,</b> <b>2,</b> <b>4</b> -TCB concentrations was shifted towards higher initial <b>1,</b> <b>2,</b> <b>4</b> -TCB concentrations with increasing cell mass. At high initial concentrations of <b>1,</b> <b>2,</b> <b>4</b> -TCB, a maximal transformation rate of approximately 37 nmol · min− 1 · mg (dry weight) − 1 was measured, irrespective of the cell concentration...|$|R
40|$|A {{series of}} perfluoroalkyl- <b>1,</b> <b>2,</b> <b>4</b> -triazole-carboxamides has been {{obtained}} through an ANRORClike rearrangement (Addition of Nucleophile, Ring-Opening and Ring-Closure) of 5 - perfluoroalkyl- <b>1,</b> <b>2,</b> <b>4</b> -oxadiazole- 3 -carboxamides with methylhydrazine or hydrazine. The initial {{addition of the}} bidentate nucleophile to the electrophilic C(5) of the <b>1,</b> <b>2,</b> <b>4</b> -oxadiazole ring, followed by ring opening and ring closure, leads {{to the formation of}} triazoles in good yield under mild experimental conditions. In some cases, a competitive ANRORC-enlargement reaction to form <b>1,</b> <b>2,</b> <b>4</b> -triazin- 6 -ones was also observed. Obtained carboxamidotriazoles have also been explored as precursors for the synthesis of 3 (5) -perfluoroalkyl- <b>1,</b> <b>2,</b> <b>4</b> -triazole...|$|R
40|$|Chemical {{properties}} of <b>1,</b> <b>2,</b> <b>4</b> -thiadiazole have been reviewed {{in the last}} few years. However, the usefulness of <b>1,</b> <b>2,</b> <b>4</b> -thiadiazole as a privileged system in medicinal chemistry has prompted the advances on the therapeutic potential of this system. This review provides a brief summary of the medicinal chemistry of <b>1,</b> <b>2,</b> <b>4</b> -thiadiazole system and highlights some examples of <b>1,</b> <b>2,</b> <b>4</b> -thiadiazole- containing drug substances in the current literature. A survey of representative literature procedures for the preparation of <b>1,</b> <b>2,</b> <b>4</b> -thiadiazole is presented in sections by generalized synthetic methods. © 2005 Elsevier Ltd. All rights reserved. Peer Reviewe...|$|R
5000|$|Oliver Wakeman - organ on ( [...] <b>1,</b> <b>2,</b> <b>4</b> [...] ) {{synthesizer}} on ( [...] 2 [...] ), piano on ( [...] <b>1,</b> <b>2,</b> <b>4,</b> 14 [...] ) ...|$|R
5000|$|Violin Elixir String Quartet - Aiko Goto (tracks: <b>1,</b> <b>2,</b> <b>4,</b> 10, 11, 13), Helena Rathbone (tracks: <b>1,</b> <b>2,</b> <b>4,</b> 10, 11, 13) ...|$|R
5000|$|... <b>1,</b> <b>1,</b> <b>2,</b> <b>1,</b> <b>2,</b> <b>1,</b> 3, <b>2,</b> <b>1,</b> 3, <b>2,</b> <b>4,</b> <b>1,</b> 3, <b>2,</b> <b>4,</b> <b>1,</b> 3, <b>2,</b> <b>4,</b> <b>1,</b> 3, 5, ...|$|R
5000|$|Jamie Muhoberac: bass (9, 10), piano (<b>1,</b> <b>2,</b> <b>4,</b> 5, 7, 9, 11), organ (<b>2,</b> <b>4,</b> 9), keys (<b>1,</b> <b>2,</b> <b>4,</b> 5, 7-11), {{programming}} (1, 3-5, 7, 9-11) ...|$|R
40|$|Tubacin {{prevents}} neuronal migration {{defects and}} epileptic activity caused by rat Srpx 2 silencing in utero Manal Salmi, <b>1,</b> <b>2,</b> 3, <b>4,</b> * Nadine Bruneau, <b>1,</b> <b>2,</b> 3, <b>4,</b> * Jennifer Cillario, <b>1,</b> <b>2,</b> 3, <b>4,</b> * Natalia Lozovaya, <b>1,</b> <b>2,</b> 3, 5 Annick Massacrier, <b>1,</b> <b>2,</b> 3, <b>4</b> Emmanuelle Buhler, <b>1,</b> <b>2,</b> 3, <b>4,</b> 6 Robin Cloarec, <b>1,</b> <b>2,</b> 3, <b>4</b> Timur Tsintsadze, <b>1,</b> <b>2,</b> 3,...|$|R
40|$|International audienceTwo {{series of}} {{mononuclear}} 3 : 1 -type iron(II) complexes {{have been obtained}} by the reaction of Fe(ClO <b>4)</b> <b>2</b> · 6 H 2 O with nine previously reported <b>1,</b> <b>2,</b> <b>4</b> -triazole-based ligands. The first series, [FeIILS 3](ClO <b>4)</b> <b>2</b> ·nH 2 O, is based on symmetrical 4 -substituted 3, 5 -di-(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazoles where LS = medpt [4 -methyl- 3, 5 -di-(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole], ibdpt [4 -isobutyl- 3, 5 -di-(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole], pmdpt [4 -(4 -methylphenyl) - 3, 5 -di-(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole], pydpt [3, 5 -di-(2 -pyridyl) - 4 -(4 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole] and pldpt [3, 5 -di-(2 -pyridyl) - 4 -(1 H-pyrrol- 1 -yl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole] whereas the complexes of the second series, [FeIILU 3](ClO <b>4)</b> <b>2</b> ·nH 2 O, incorporate unsymmetrical 4 -substituted 3 -phenyl- 5 -(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazoles with LU = meppt [4 -methyl- 5 -phenyl- 3 -(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole], ibppt [4 -isobutyl- 3 -phenyl- 5 -(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole], pmppt [4 -(4 -methylphenyl) - 3 -phenyl- 5 -(2 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole] and pyppt [3 -phenyl- 5 -(2 -pyridyl) - 4 -(4 -pyridyl) - <b>4</b> H- <b>1,</b> <b>2,</b> <b>4</b> -triazole]. The complexes have been investigated by 1 H NMR spectroscopy and found {{to be in the}} low-spin state at room temperature. Single crystal X-ray diffraction studies of the complexes [FeII(pmdpt) 3](ClO <b>4)</b> <b>2</b> ·MeCN· 0. 5 H 2 O (I), [FeII(ibdpt) 3](ClO <b>4)</b> <b>2</b> · 2 H 2 O (II) and [FeII(ibppt) 3](BF <b>4)</b> <b>2</b> · <b>1.</b> 34 MeOH· 0. 16 H 2 O (III) have revealed meridional arrangements of the ligands and distorted octahedral FeN 6 coordination environments about the respective low-spin iron(II) centres...|$|R
5000|$|Lyrics: Alex Christensen (tracks: <b>1,</b> <b>2,</b> <b>4,</b> 6, 7, 9, 12), Frank Peterson (tracks: <b>1,</b> <b>2,</b> <b>4,</b> 7, 9, 12), Joe Paquette, Mark Wahlberg ...|$|R
